What Does the Street Think About Alphatec Holdings (ATEC)?

Alphatec Holdings, Inc. (NASDAQ:ATEC) is one of the best small-cap stocks with huge growth potential. On TD Cowen cut the price target on Alphatec Holdings, Inc. (NASDAQ:ATEC) to $20 from $27 on January 26, maintaining a Buy rating on the shares after a transfer of coverage. The firm sees the company’s “growth vectors” as not being fully appreciated in Street expectations, which creates potential upside to estimates.

Alphatec Holdings, Inc. (NASDAQ:ATEC) also received a rating update from Lake Street on January 20, reiterating a Buy rating on the shares and setting a price target of $25.

In its preliminary financial results for fiscal Q4 and the full-year ended December 31, 2025, Alphatec Holdings, Inc. (NASDAQ:ATEC) announced that the preliminary total revenue rose approximately 25% in the full year 2025. Management stated that strong surgeon adoption drove full-year 2025 surgical revenue growth of 26%, with surgical volume growth of 24% and average revenue per procedure growth of 2%.

Strong revenue growth is continually driving leverage, with the company reaffirming its full-year 2025 adjusted EBITDA guidance of $91 million. Alphatec Holdings, Inc. (NASDAQ:ATEC) also provided a financial outlook for full year 2026, stating that it expects full-year 2026 total revenue of $890 million.

Alphatec Holdings, Inc. (NASDAQ:ATEC) designs, develops, and markets spinal fusion technology products and solutions to treat spinal disorders. The company’s offerings include intra-operative information and neuromonitoring technologies, fixation systems, access systems, interbody implants, and various biologics offerings.

While we acknowledge the potential of ATEC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.